BGI Genomics Gets Australian Regulatory Approval for Multiplexed SARS-CoV-2, Influenza Test
The RT-PCR-based test is designed to simultaneously detect and differentiate SARS-CoV-2, influenza A, and influenza B from throat swab samples.
The new SpotFire system is significantly faster than other CLIA-waived syndromic tests, and a new test menu could provide even more advantages, the firm said.
The Spanish company last week announced that it raised €13 million in Series B financing to fund its efforts to supplant culture-based methods with molecular testing.
Becton Dickinson Gets CE-IVD Mark for BD Max Combined COVID, Flu, RSV Panel
The firm also plans to submit the assay to the US Food and Drug Administration for Emergency Use Authorization in the coming weeks.
BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel
The panel includes additional pathogen targets and resistance genes, as well as revised targets compared to the original BCID panel.